Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

✍ Scribed by Catherine Sebban; Sophie Dussart; Christine Fuhrmann; Hervé Ghesquieres; Isabelle Rodrigues; Lionel Geoffrois; Yves Devaux; Laurence Lancry; Giselle Chvetzoff; Thomas Bachelot; Maria Chelghoum; Pierre Biron

• Publisher: Springer-Verlag
• Year: 2008
• Tongue: English
• Weight: 134 KB
• Volume: 16
• Category: Article
• ISSN: 0941-4355
• DOI: 10.1007/s00520-007-0383-z